Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -136.06% | 13.99% | -18.07% | -19.58% | 16.62% |
| Total Depreciation and Amortization | -48.20% | 36.30% | 70.18% | 68.73% | 27.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,501.49% | 77.33% | 13.69% | -23.65% | -49.56% |
| Change in Net Operating Assets | -112.99% | -176.74% | -31.65% | 24.55% | 1,283.29% |
| Cash from Operations | -136.18% | -6.74% | -31.76% | -11.70% | 64.49% |
| Capital Expenditure | 94.21% | 96.41% | 97.65% | 97.88% | 12.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,242.42% | 200.92% | 88.43% | -- | -- |
| Cash from Investing | 639.46% | 160.39% | 88.96% | 684.23% | -67.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.23% | -82.42% | -99.99% | 23.74% | -99.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -59.23% | -82.42% | -99.99% | 23.74% | -99.36% |
| Foreign Exchange rate Adjustments | 1,975.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.02% | 66.16% | 38.23% | 131.07% | -107.66% |